Anika Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +30.8% | -76.5% | -335.4% | – | – | +506.0% | +1,084.1% | -72.9% | -69.0% | +124.5% | -24.2% | -9.2% | +153.8% | +29.5% | +3.7% | +138.6% | +58.9% | -2.3% | -39.1% | +71.5% | -14.4% | +6.0% | -64.7% | -35.7% | -47.5% | -140.6% | – | +107.1% | |
| – | -50.0% | +166.7% | +37.5% | +8.9% | +3.0% | -11.2% | -8.1% | -29.4% | -35.4% | -16.3% | +113.2% | +75.0% | -9.7% | +156.7% | +20.5% | +13.1% | +5.5% | -1.4% | -19.8% | -1.1% | +14.9% | +37.8% | +1.4% | +150.3% | -4.5% | +1.2% | -1.9% | -42.9% | -29.5% | |
| – | – | – | – | – | – | – | – | – | – | – | -28.1% | -99.8% | -31.2% | +15.1% | +8.0% | -3.3% | +10.2% | +26.8% | +38.4% | +52.4% | +71.2% | +90.2% | -44.9% | -11.5% | +105.8% | +29.1% | +6.5% | -13.9% | -23.2% | |
| – | – | – | – | – | – | – | – | – | – | – | +58.7% | -93.5% | – | – | – | -15.1% | -34.6% | -349.2% | – | +114.8% | +108.6% | +90.9% | -31.2% | +163.4% | -114.3% | – | – | – | – | |
| – | -340.0% | – | – | – | – | +109.8% | -91.8% | +12,036.8% | -113.5% | – | – | – | – | – | – | – | – | – | -21.8% | -636.9% | – | – | – | – | – | – | – | – | – | |
| – | -25.0% | +633.3% | -22.7% | -70.3% | +79.8% | -90.2% | +187.9% | +85.2% | +237.6% | -18.4% | +1,030.0% | +10.1% | -75.6% | -29.7% | -49.7% | +7.5% | -70.7% | +252.2% | +494.0% | +51.9% | -35.9% | -48.2% | -39.3% | -42.4% | +215.9% | +45.6% | -27.5% | +42.5% | -11.7% | |
| – | – | +3,500.0% | -74.3% | – | +61.4% | -68.6% | -7.5% | -76.8% | -565.1% | -18.4% | +1,300.1% | -30.0% | +57.9% | -86.7% | -47.7% | +7.5% | -83.2% | +3,179.8% | +264.0% | -77.6% | +84.5% | +302.7% | – | -279.5% | -95.6% | +140.1% | -27.5% | +53.6% | -95.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -49.1% | -60.6% | – | – | – | |
| – | – | – | -2.6% | – | – | – | – | – | – | – | – | – | – | – | – | +142.2% | +685.7% | -307.9% | – | -2,427.7% | – | -9,654.1% | +0.0% | -99.1% | +85.5% | +92.2% | +435.3% | +118.3% | -13.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +500.0% | – | – | – | – | +0.0% | +0.0% | -37.3% | -42.6% | +41.3% | -100.0% | – | – | |
| – | +8,750.0% | -105.6% | +40.0% | – | +0.0% | – | – | +522.6% | -4.0% | +210.3% | +46.4% | +560.6% | -109.8% | -18.6% | -12.9% | -34.9% | +649.7% | – | -64.0% | -1,315.3% | – | -9,305.1% | -71.8% | -53.6% | +79.6% | -28.4% | +30.3% | +101.3% | -17.1% | |
| – | – | -160.3% | – | – | -56.2% | +142.4% | +85.4% | +589.3% | -78.1% | -55.2% | -565.3% | – | -357.4% | – | +100.7% | +9.4% | +132.4% | +91.1% | -71.3% | -161.1% | – | -252.5% | – | -190.1% | – | – | – | – | – | |
| – | – | -47.8% | -175.0% | – | – | – | +622.3% | +1,229.7% | -79.2% | -85.7% | -1,575.9% | – | – | – | +73.1% | +3.1% | +173.4% | +55.4% | -22.3% | -67.2% | +225.2% | -4.9% | +12.9% | -66.5% | -71.5% | -194.6% | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.